Cite
HARVARD Citation
Berghoff, A. et al. (n.d.). OS01.5.A Neuron-specific enolase (NSE) and S100 serum levels in patients with active brain metastases from HER2-positive breast cancer treated with trastuzumab-deruxtecan (T-DXd): A biomarker analysis from the TUXEDO-1 trial. Neuro-oncology. p. ii10. [Online].